P2RX7 and colon adenocarcinoma: Multivariate Cox analysis also showed that P2RX7 is an independent prognostic factor for stage III COAD patients who received adjuvant chemotherapy (HR = 1.47, 95% CI = 1.08–1.99, p = 0.014, Fig. 7E, Table S5).